Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
|Study ID||Alternative Stable ID||Type|
Study Datasets 3 datasets.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
This dataset contains RNAseq data of 20 paired pre-post neoadjuvant chemotherapy breast cancer samples. In total the set contains n=20 biopsies, n=20 surgery specimens. Each sample has 2 fastq files, so n=80 fastq files are uploaded in total.
|Illumina HiSeq 2000||40|
This dataset contains RNAseq data of n=87 pre-treatment biopsies of triple negative and luminal- type breast cancer patients, all scheduled to receive neoadjuvant chemotherapy. Gene expression data is linked with treatment response and survival.
|Illumina HiSeq 2000||1|
This dataset contains whole exome sequencing data (WES) of 20 paired pre- and post neoadjuvant chemotherapy breast cancer samples. From every patient a pre-treatment biopsy (B) and a post-treatment surgery (S) specimen has been sequenced. From most patients a paired normal blood sample (N) has been sequenced as a reference control.
|Illumina HiSeq 2500||1|